MedPath

Artificial Intelligence-assissted Glaucoma Evaluation

Completed
Conditions
Artificial Intelligence
Glaucoma
Registration Number
NCT03268031
Lead Sponsor
Sun Yat-sen University
Brief Summary

Glaucoma is currently the second leading cause of irreversible blindness in the world. Our study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.

Detailed Description

Glaucoma is currently the second leading cause of irreversible blindness in the world, which brings heavy burden to human society. Compared to other ocular diseases, diagnostic process of glaucoma is complicated depends on multiple test results, including visual field test, OCT, etc. How to diagnose glaucoma correctly and fast has always been a hot topic in glaucoma researches. Artificial intelligence is used to study and develop theories and methods that can help simulate and extend human intelligence, which has been utilized in a lot of research fields such as automatic drive and medicine. The study intends to combine clinical data of glaucoma patients in Zhongshan Ophthalmic Center with Artificial Intelligence techniques to create programs that can screen and diagnose glaucoma.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10800
Inclusion Criteria
  1. BCVA>0.1
  2. able to complete reliable visual field test
  3. no history of intraocular surgery or fundus laser
Exclusion Criteria
  1. unable to complete visual field test

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Accuracy of diagnosis by artificial intelligence algorithmfrom August 2017 to February 2021

Accuracy of diagnosis by artificial intelligence algorithm and compare this result with glaucoma specialists

Secondary Outcome Measures
NameTimeMethod
Specificity of diagnosis by artificial intelligence algorithmfrom August 2017 to February 2021

Specificity of diagnosis by artificial intelligence algorithm

Sensitivity of diagnosis by artificial intelligence algorithmfrom August 2017 to February 2021

Sensitivity of diagnosis by artificial intelligence algorithm

Trial Locations

Locations (1)

Zhongshan Ophthalmic Center

🇨🇳

Guangzhou, Guangdong, China

Zhongshan Ophthalmic Center
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.